Clinical Trial Update: The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating insulin degludec in combination with liraglutide and metformin in Type 2 diabetes patients eligible for treatment intensification; stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• insulin degludec (insulin degludec)
• liraglutide (liraglutide)
• metformin (metformin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2016-04-20